Gender differences in the prevalence and severity of bone disease in Thalassaemia

Pediatric Endocrinology Reviews

Volumn 6, Issue SUPPL. 1, 2008, Pages 116-122

  Kyriakou, Andreas ^a   Savva, Savvas C ^b   Savvides, Irene ^a   Pangalou, Evdokia ^a   Ioannou, Yiannis S ^a   Christou, Soteroulla ^a   Skordis, Nicos ^a  

^a Archbishop Makarios III Hospital   (Cyprus)

^b Research and Education Institute of Child Health   (Cyprus)

Author keywords

BMD; Endocrine complications; Gender; Osteoporosis; Thalassaemia

Indexed keywords

DEFERIPRONE; DEFEROXAMINE; FERRITIN;

ADOLESCENT; ADULT; ARTICLE; BONE DENSITY; BONE DISEASE; BONE MASS; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOCRINE DISEASE; FEMALE; FEMUR NECK; GENDER; HEART; HUMAN; HYPOGONADISM; IRON OVERLOAD; LIVER; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPENIA; OSTEOPOROSIS; PATHOGENESIS; PATHOPHYSIOLOGY; SEX DIFFERENCE; THALASSEMIA;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BONE DENSITY; CYPRUS; FEMALE; HUMANS; IRON OVERLOAD; MALE; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE; RETROSPECTIVE STUDIES; SEX FACTORS; YOUNG ADULT;

EID: 58149481345     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Angastiniotis M, Pavlides N, Aristidou K, Kanakas A, Yerakaris M, Eracleous E, Posporis T. Bone pain in thalassaemia: assessment of DEXA and MRI findings. J Pediatr Endocrinol Metab 1998;11(Suppl. 3):779-784
2. Giardina PJ, Schneider R, Lesser M, Simmons B, Rodriquez A, Gertner J, New M, Hilgartner MW. Abnormal bone metabolism in thalassaemia. In: Endocrine disorders in thalassaemia. Berlin: Springer 1995;39-46
3. Voskaridou E, Kyrtsonis MC, Terpos E, Skordili M, Theodoropoulos I, Bergele A, Diamanti E, Kalovidouris A, Loutradi A, Loukopoulos D. Bone resorption is increased in young adults with thalassemia major. Br J Haematol 2001;112:36-41
4. Dresner-Pollack R, Rachmilewitz E, Blumenfeld A, Idelson M, Goldfarb AW. Bone mineral metabolism in adults with beta-thalassaemia major and intermedia. Br J Haematol 2000;111:902-907
5. Salama OS, Al-Tonbary YA, Shahin RA, Eldeen OA. Unbalanced bone turnover in children with beta-thalassemia. Hematology 2006;11:197-202
6. De Sanctis V, Stea S, Savarino L, Scialpi V, Traina GC, Chiarelli GM, Sprocati M, Govoni R, Pezzoli D, Gamberini R, Rigolin F. Growth hormone secretion and bone histomorphometric study in thalassaemic patients with acquired skeletal dysplasia secondary to desferrioxamine. J Ped Endocrinol Metab 1998;11(Suppl 3):827-833
7. Olivieri, NF, Koren G, Harris J, Khattak S, Freedman MH, Templeton DM, Bailey JD, Reilly BJ. Growth failure and bony changes induced by deferoxamine. Am J Pediatr Hematol Oncol 1992;14:48-56
8. De Virgillis S, Congio M, Frau F, Argiolu F, Diana G, Cucca F, Varsi A, Sanna G, Podda G, Fodde M, Pirastu GF, Cao A. Desferrioxamine induced growth retardation in patients with thalassaemia major. J Pediatr 1988;113:661-669
9. Voskaridou E, Terpos E. New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia. Br J Haematol 2004;123:730-737
10. Anapliotou ML, Kastanias IT, Psara P, Evangelou EA, Liparaki M, Dimitriou P. The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approaches. Clin Endocrinol 1995;42:279-287
11. Tiosano D, Hochberg Z. Endocrine complications of thalassemia. J Endocrinol Invest 2001;24:716-723
12. Jensen CE, Tuck SM, Agnew JE, Koneru S, Morris RW, Yardumian A, Prescott E, Hoffbrand AV, Wonke B. High prevalence of low bone mass in thalassaemia major. Br J Haematol 1998;103:911-915
13. Soliman AT, El Banna N, Abdel Fattah M, El Zalabani MM, Ansari BM. Bone mineral density in prepubertal children with beta-thalassemia: correlation with growth and hormonal data. Metab 1998;47:541-548
14. Lasco A, Morabito N, Gaudio A, Crisafulli A, Meo A, Denuzzo G, Frisina N. Osteoporosis and beta-thalassemia major: role of the IGF-1/IGFBP-III axis. J Endocrinol Invest 2002;25:338-344
15. Skordis N. The growing child with thalassaemia. J Ped Endocrinol Metab 2006;19:467-469
16. Toumba M, Sergis A, Kanaris C, Skordis N. Endocrine complications in patients with thalassaemia major. Pediatr Endocrinol Rev 2007;5:642-648
17. Bielinski BK, Darbyshire PJ, Mathers L, Crabtree NJ, Kirk JM, Stirling HF, Shaw NJ. Impact of disordered puberty on bone density in beta-thalassaemia major. Br J Haematol 2003;120:353-358
18. Origa R, Fiumana E, Gamberini MR, Armari S, Mottes M, Sangalli A, Paglietti E, Galanello R, Borgna-Pignatti C. Osteoporosis in □-thalassemia: clinical and genetic aspects. Ann NY Acad Sci 2005;1054:451-456
19. Christoforidis A, Hatzipantelis E, Tsatra I, Katzos G, Athanasiou-Metaxa M. Bone mineral density in children and young adults with beta-thalassemia major conventionally treated. Pediatr Blood Cancer 2006;47:113-114
20. Garofalo F, Piga A, Lala R, Chiabotto S, Di Stefano M, Isaia GC. Bone metabolism in thalassemia. Ann NY Acad Sci 1998;850:475-478
21. Vogiatzi G, Autio A, Mait E, Schneider R, Lesser M, Giardina PJ. Low bone mineral density in adolescents with beta-thalassemia. Ann NY Acad Sci 2005;1054:462-466
22. Shamshirsaz AA, Bekheirnia MR, Kamgar M, Pakbaz Z, Tabatabaie SM, Bouzari N, Pourzahedgilani N, Azarkeivan A, Hashemi SR, Moosavi F, Alebouyeh M, Vosough P, Kimiagar M, Shamshirsaz AA, Morabi M, Habibzadeh MR, Nobakhthaghighi N, Larijani B. Bone mineral density in Iranian adolescents and young adults with thalassemia major. Pediatr Hematol Oncol 2007;24:469-479
23. Mahachoklertwattana P, Chuansumrit A, Sirisriro R, Choubtum L, Sriphrapradang A, Rajatanavin R. Bone mineral density, biochemical and hormonal profiles in suboptimally treated children and adolescents with beta-thalassaemia disease. Clin Endocrinol (Oxf) 2003;58:273-279
24. Lasco A, Morabito N, Gaudio A, Bruno M, Wasniewska M, Frisina N. Effects of hormonal replacement therapy on bone metabolism in young adults with beta thalassemia major. Osteoporos Int 2001;12:570-575
25. Carmina E, Di Fede G, Napoli N, Renda G, Vitale G, Lo Pinto C, Bruno D, Malizia R, Rini GB. Hypogonadism and hormone replacement therapy on bone mass of adult women with thalassemia major. Calcif Tissue Int 2004;74:68-67
26. Skordis N, Michaelidou M, Savva SC, Ioannou Y, Rousounides A, Kleanthous M, Scordos G, Christou S. The impact of genotype on endocrine complications in thalassaemia major. Eur J Haematol 2006;77:150-156
27. Morabito N, Gaudio A, Lasco A, Atteritano M, Pizzoleo M.A, Cincotta M, La Rosa M, Guarino R, Meo A, Frisina N. Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle. J Bone and Miner Res 2004;19:722-727
28. Riggs BL. The mechanisms of estrogen regulation of bone resorption. J Clin Investig 2000;106:203-204
29. Olszynski W, Shawn D, Davison K, Adachi D, Brown P, Cummin R, Hanley D, Harris P, Hodsman B, Kendler D, McClung R, Miller D, Yuen K. Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment. Clin Therap 2004;26:15-28
30. Praticò G, Di Gregorio F, Caltabiano L, Palano GM, Morana M, Caruso-Nicoletti M. Bone metabolism markers in thalassemia. Pediatr Med Chir 2001;23:35-39
31. Karimi M, Habibzadeh F, De Sanctis V. Hypoparathyroidism with extensive intracerebral calcification in patients with beta-thalassaemia major. J Pediatr Endocrinol Metab 2003;16:883-886
32. Perotta S, Capellini MD, Bertoldo F, Servedio V, Iolascon G, D'Agruma L, Gasparini P, Siciliani MC, Iolascon A. Osteoporosis in □-thalassemia major patients: analysis of the genetic backround. Br J Haematol 2000;111:461-466
33. Rubin K, Schirduan V, Gendreu P, Sarfarazi M, Mendota R, Dalsky G. Predictors of axial and peripheral bone mineral density in healthy children and adolescents, with special attention to the role of puberty. J Pediatr 1993;123:863-870
34. Mahachoklertwattana P, Sirikulchayanonta V, Chuansumrit A, Karnsombat P, Choubtum L, Sriphrapradang A, Domrongkitchaiporn S, Sirisriro R, Rajatanavin R. Bone histomorphometry in children and adolescents with beta-thalassemia disease: iron-associated focal osteomalacia. J Clin Endocrinol Metab 2003;88:3966-3972
35. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, Pennell DJ. Cardiovascular T2-star (T2) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-2179
36. Mylona M, Leotsinides M, Alexandrides T, Zoumbos N, Dimopoulos PA. Comparison of DXA, QCT and trabecular structure in beta-thalassaemia. Eur J Haematol 2005;74:430-437
37. Seeman E. Growth in bone mass and size - are racial and gender differences in bone mineral density more apparent than real? J Clin Endocrinol Metab 1998;83:1414-1419